arrow
返回
X

Xi Jin

Beijing Normal University

33H指数
170论文数
3.6K被引数
收录论文 75
发表时间
NAD plus -Dependent Enzyme SIRT3 Limits Intestinal Epithelial Cell Functions Through NAD plus Synthesis Pathway in Colorectal Cancer
err2026-01-01
err0
errOAAI
errNiu, Ruiying; Dong, Yingjie; Tong, Jianghui; Xia, Jingxuan; Zhao, Longhao; Geng, Zi; Lin, Yingxin; Zhang, Jinghe; Liu, Xinyi; Fang, Manqi; Jin, Xi; Bi, Yujing; Liu, Guangwei
err分享
err收藏
Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial)Sitravatinib联合tislelizumab治疗局部复发或转移性三阴性乳腺癌: 一项多队列,单臂,II期临床试验 (SPARK试验)
err2025-12-19
err0
errOAAI
errXi-Yu Liu; Xin-Yi Sui; Ying Xu; Fan Yang; Song-Yang Wu; Xiu-Zhi Zhu; Ke Zuo; Shuo-Wen Cao; Xi Jin; Li Chen; Lin-Xiaoxi Ma; Wen-Juan Zhang; Fu-Gui Ye; Fei-Lin Qu; Ding Ma; Yi Xiao; Gen-Hong Di; Guang-Yu Liu; Ke-Da Yu; Jiong Wu; Xin Hu; Yi-Zhou Jiang; Zhong-Hua Wang; Zhi-Ming Shao; Lei Fan
err分享
err收藏
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial人工智能辅助分型指导的精准治疗可提高HR+/HER2−乳腺癌的疗效:LINUX试验
err2025-12-04
err0
PREAI
errLei Fan; Wen-Juan Zhang; Hui-Ping Li; Xiao-Hua Zeng; Yue-E Teng; Yue Gong; Xi Jin; Shen Zhao; Tao Sun; Wen-Yan Chen; Shu-Sen Wang; Jin Yang; Zhi-Gang Zhuang; Su-Jie Ni; Zhi-Xian He; De-Yuan Fu; Chuan-Gui Song; Zheng Lv; Qian-Nan Liang; Bao-Hua Yu
err分享
err收藏
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer干扰素诱导的衰老CD8+ T细胞降低了早期三阴性乳腺癌中抗PD1免疫治疗的有效性
err2025-09-10
err0
PREAI
errTong Fu; Xi Jin; Min He; Yi-Yu Chen; Yun-Song Yang; Li Chen; Hu-Yun-Long Zhang; Lei Fan; Jiong Wu; Zhong-Hua Wang; Yi-Wei Chu; Rong-Hua Liu; Yi-Zhou Jiang; Zhi-Ming Shao
err分享
err收藏
The Impacts of Ethylicin on Absorption, Transport, and Growth in Tomato Plants
err2025-02-28
err0
errOAAI
errZheng, Yiwen; Liu, Shenyan; Ren, Lirui; Zeng, Tao; Wen, Xiangling; Wang, Shaolong; Jin, Xi; Hao, Zheng; Gao, Shimeng; Gao, Jie; Cao, Aocheng
err分享
err收藏
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer (vol 13, 6, 2025)MORF4L2通过GRHL2/MORF4L2/H4K12Ac/CSF1轴诱导免疫抑制性微环境并导致三阴性乳腺癌对免疫治疗的抵抗(卷13,期6,2025)
err2025-02-13
err0
errOAAI
errSui, Xin-Yi; Cao, Shuo-Wen; Song, Xiao-Qing; Liu, Xi-Yu; Chen, Chao; Yan, Qingya; Wang, Zhi-Qing; Zhang, Wen-Juan; Ma, Lin-Xiaoxi; Jin, Xi; Ma, Ding; Xiao, Yi; Wu, Song-Yang; Xu, Ying; Shao, Zhi-Ming; Fan, Lei
err分享
err收藏
Targeting transposable elements in cancer: developments and opportunities
err2024-09-01
err0
PREAI
errWang, Zi-Yu; Ge, Li-Ping; Ouyang, Yang; Jin, Xi; Jiang, Yi-Zhou
err分享
err收藏
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic StrategiesHER2-Positive乳腺癌的分子特征和分类为量身定制的治疗策略提供了依据
err2024-08-26
err0
PREAI
errLi, Yu-Wei; Dai, Lei-Jie; Wu, Xiang-Rong; Zhao, Shen; Xu, Yu-Zheng; Jin, Xi; Xiao, Yi; Wang, Ying; Lin, Cai-Jin; Zhou, Yi-Fan; Fu, Tong; Yang, Wen-Tao; Li, Ming; Lv, Hong; Chen, Siyuan; Grigoriadis, Anita; Jiang, Yi-Zhou; Ma, Ding; Shao, Zhi-Ming
err分享
err收藏
Phase II study of sitravatinib plus tislelizumab with or without nab-paclitaxel in patients with locally recurrent or metastatic triple negative breast cancer
err2024-05-02
err1
PREAI
errFan, Lei; Liu, Xiyu; Xu, Ying; Sui, Xinyi; Zhang, Wenjuan; Ma, Linxiaoxi; Jin, Xi; Wu, Song-Yang; Wang, Han; Xiao, Yi; Chen, Li; Wu, Jiong; Yu, Ke-da; Liu, Guangyu; Hu, Xin; Wang, Zhonghua; Jiang, Yi-Zhou; Shao, Zhi-Ming
err分享
err收藏
Subtyping-directed precision treatment refines traditional one-size-fits-all therapy in HR+/HER2-breast cancer: a sub-study of the MULAN umbrella trial
err2024-05-02
err0
PREAI
errZhu, Xiu-Zhi; Jin, Xi; Zhang, Hu-Yun-Long; Liu, Xiyu; Zhou, Yi-Fan; Chen, Yi-Yu; Fu, Tong; Jin, Ming-Liang; Zhao, Ya-Xin; Xie, Yi-Fan; Wang, Ruo-Xi; Wang, Zhong-Hua; Fan, Lei; Jiang, Yi-Zhou; Shao, Zhi-Ming
err分享
err收藏
Genomic characterization of triple-negative breast cancer metastases reveals PKD1 as a novel biomarker for immunotherapy
err2024-05-02
err0
PREAI
errZhu, Xiu-Zhi; Zhou, Yi-Fan; Wang, Yun-Yi; Ding, Xiao-Hong; Jin, Xi; Shao, Zhi-Ming; Jiang, Yi-Zhou; Wang, Zhong-Hua
err分享
err收藏
Comprehensive characterization of genetic interactions in breast cancer reveals therapeutic vulnerabilities
err2024-05-02
err0
PREAI
errLin, Caijin; Jin, Xi; Ma, Ding; Chen, Chao; Hu, Xin; Jiang, Yi-Zhou; Shao, Zhi-Ming
err分享
err收藏
Programme of mast cell subsets to potentiate breast cancer immunotherapy: from bed to bench to bed (the phase 2 platform RENAISSANCE trial)
err2024-05-02
err0
PREAI
errWu, Song-Yang; Jin, Xi; Liu, Yin; Zuo, Wen-Jia; Chen, Li; Liu, Xiyu; Fan, Lei; Wang, Zhong-Hua; Liu, Yan-Fei; Jiang, Yi-Zhou; Shao, Zhi-Ming
err分享
err收藏